A predicting model of bone marrow malignant infiltration in 18F-FDG PET/CT images with increased diffuse bone marrow FDG uptake

被引:15
|
作者
Zhou, Mingge [1 ]
Chen, Yumei [1 ]
Liu, Jianjun [1 ]
Huang, Gang [1 ,2 ,3 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai, Peoples R China
[2] Chinese Acad Sci, Inst Hlth Sci, Dept Canc Metab, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] Shanghai Univ Med & Hlth Sci, Key Lab Mol Biol & Imaging, Shanghai, Peoples R China
来源
JOURNAL OF CANCER | 2018年 / 9卷 / 10期
基金
中国国家自然科学基金;
关键词
bone marrow; malignant infiltration; predicting model; PET/CT; SUVmax; CHRONIC MYELOID-LEUKEMIA; INVOLVEMENT; LYMPHOMA; PATIENT;
D O I
10.7150/jca.24836
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To demonstrate the relationship between the etiologies of increased diffuse bone marrow (BM) F-18-FDG uptake and PET/CT imaging/clinical features, as well as to explore a predicting model of BM malignant infiltration (MI) based on decision tree. Methods: 84 patients with increased diffuse BM uptake were retrospectively enrolled. Their complete case record and PET/CT images were reviewed, with the maximal standardized uptake values of bone marrow (SUVmaxBM) and other imaging/clinical features were noted. At the same time, the differences in imaging/clinical features between bone marrow MI and non-MI groups were compared. The decision tree for predicting MI was established by C5.0 component of SPSS Clementine. Results: In patients with homogenously increased BM uptake, 21 patients had MI resulted from leukemia, lymphoma and small cell lung cancer (SCLC). MI group had higher SUVmaxBM than non-MI group (6.7 +/- 3.1 vs 4.2 +/- 0.9, p=0.001). However, a considerable proportion of MI patients had similar SUVmaxBM to non-MI patients, which were mainly seen in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM), chronic myeloid leukemia (CML) and multiple myeloma (MM). There were significant differences in other factors between the two groups. MI patients were highly associated with SUVmaxAP/AX >= 1 (the ratio of SUVmaxBM of appendicular skeleton to that of axial skeleton), hepatosplenomegaly, older age and lower rate of fever. The decision tree combining SUVmaxBM, SUVmaxAP/AX, fever and hepatosplenomegaly achieved a sensitivity of 81.0%, a specificity of 98.4% and an accuracy of 94.0% for predicting MI. Conclusion: Increased diffuse BM F-18-FDG uptake can be attributed to both bone marrow MI and benign etiologies. A decision tree based on C5.0 algorithm, combining PET/CT imaging and clinical features, is of potential use in discriminating BM malignant infiltration from patients with increased diffuse BM uptake.
引用
收藏
页码:1737 / 1743
页数:7
相关论文
共 50 条
  • [31] Spectrum of the prostate lesions with increased FDG uptake on 18F-FDG PET/CT
    Dong, Aisheng
    Bai, Yushu
    Wang, Yang
    Zuo, Changjing
    Lu, Jianping
    ABDOMINAL IMAGING, 2014, 39 (04): : 908 - 921
  • [32] Diffuse Hypermetabolic Bone Marrow Infiltration in Severe Primary Hyperoxaluria on FDG PET
    Tonnelet, David
    Benali, Khadija
    Rasmussen, Camille
    Goulenok, Tiphaine
    Piekarski, Eve
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (06) : E296 - E298
  • [33] Diagnostic performance of 18F-FDG PET/CT in pediatric lymphoma infiltrating bone marrow: a meta-analysis
    Xianwen Hu
    Dandan Li
    Guomei Hu
    Qi Huang
    Pan Wang
    Jiong Cai
    Clinical and Translational Imaging, 2021, 9 : 511 - 522
  • [34] F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients
    Mostard, Remy L.
    Prompers, Leonne
    Weijers, Rene E.
    van Kroonenburgh, Marinus J.
    Wijnen, Petal A.
    Geusens, Piet P.
    Drent, Marjolein
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (01) : 21 - 25
  • [35] Diagnostic Efficacy of 18F-FDG PET/CT in Detecting Bone Marrow Infiltration in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
    Guo, Bo
    Qin, Ran
    Gu, Zhen Yang
    Li, Yan Fen
    Gao, Lei
    Huang, Wen Rong
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2023, 36 (06) : 510 - 516
  • [36] Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams, Hugo J. A.
    de Klerk, John M. H.
    Fijnheer, Rob
    Heggelman, Ben G. F.
    Dubois, Stefan V.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (01) : 23 - 29
  • [37] Multifocal Hemorrhagic Choriocarcinoma With Diffuse Pancreatic FDG Uptake on 18F-FDG PET/CT
    Dai, Sheng
    Dong, Youwen
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : e110 - e112
  • [38] 18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging
    Gerard Moulin-Romsee
    Elif Hindié
    Xavier Cuenca
    Pauline Brice
    Didier Decaudin
    Myriam Bénamor
    Josette Brière
    Marcela Anitei
    Jean-Emmanuel Filmont
    David Sibon
    Eric de Kerviler
    Jean-Luc Moretti
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1095 - 1105
  • [39] The Impact of Bone Marrow Involvement on Prognosis in Diffuse Large B-Cell Lymphoma: An 18F-FDG PET/CT Volumetric Segmentation Study
    Doma, Andrej
    Studen, Andrej
    Novakovic, Barbara Jezersek
    CANCERS, 2024, 16 (22)
  • [40] The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma
    El-Azony, Ahmed
    Basha, Mohammad Abd Alkhalik
    Almalki, Yassir Edrees
    Abdelmaksoud, Bader
    Hefzi, Nabila
    Alnagar, Ahmed A.
    Mahdey, Sheren
    Ali, Ismail Mohamed
    Nasr, Ibrahim
    Abdalla, Ahmed A. El-Hamid M.
    Yousef, Hala Y.
    Zaitoun, Mohamed M. A.
    Elsayed, Saeed Bakry
    Nada, Mohamad Gamal
    Amin, Mohamed I.
    Hassan, Rania Mostafa
    Ali, Susan Adil
    Dawoud, Tamer Mahmoud
    Aly, Sameh Abdelaziz
    Algazzar, Youssef H.
    Abdelhamed, Heba
    EUROPEAN RADIOLOGY, 2024, 34 (04) : 2500 - 2511